
IndraLab
Statements
Lipopolysaccharide inhibits IRF3. 18 / 18
|
18
reach
"TMED7 overexpression inhibits the ability of TRAM, an adaptor utilized by toll like receptor 4, or lipopolysaccharide to activate the interferon regulatory factor 3 signalling pathway, whereas TMED7 knockdown enhances production of the cytokine, RANTES, following lipopolysaccharide stimulation."